Moderna Inc $ 57.72 -2.87 (-4.73%)
Volume:
5,886,364
Avg Vol (1m):
23,787,027
Market Cap $:
21.51 Bil
Enterprise Value $:
20.44 Bil
P/E (TTM):
0.00
P/B:
12.48
Financial Strength | 6/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 8.24 | ||
| Equity-to-Asset | 0.79 | ||
| Debt-to-Equity | 0.09 | ||
| Debt-to-EBITDA | -0.32 | ||
| Altman Z-Score | 30.41 | ||
Profitability Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -1017.16 | ||
| Net Margin % | -961.7 | ||
| ROE % | -36.89 | ||
| ROA % | -28.93 | ||
| ROC (Joel Greenblatt) % | -205.34 | ||
| 3-Year Revenue Growth Rate | -20.7 | ||
| 3-Year EBITDA Growth Rate | -27.1 | ||
| 3-Year EPS without NRI Growth Rate | -22 |
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 12.48 | ||
| PS Ratio | 366.77 | ||
| EV-to-EBIT | -40.93 | ||
| EV-to-EBITDA | -43.66 | ||
| EV-to-Revenue | 388.83 | ||
| Current Ratio | 9.29 | ||
| Quick Ratio | 9.29 | ||
| Days Sales Outstanding | 50.68 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.7 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 12.46 | ||
| Earnings Yield (Greenblatt) % | -2.43 |